BKI 1708 is a potent and orally active calcium-dependent protein kinase 1 ( CDPK1 ) inhibitor ( IC 50 = 0.7 nM). BKI 1708 exhibits potent activity against Neospora ( IC 50 = 481 nM) and Toxoplasma ( IC 50 = 122 nM). BKI-1708 induces the formation of multinucleated complexes. BKI-1708 efficiently inhibits vertical transmission of both parasites and increases pup survival in mice.
Products | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Parasite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.